Current concepts of the immunobiology and immunotherapy of cutaneous T cell lymphoma: Insights gained through cross-talk between the clinic and the bench

Leukemia and Lymphoma

Volumn 44, Issue 10, 2003, Pages 1697-1703

  Berger, Carole L ^a   Edelson, Richard L ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer vaccine; CTCL; Dendritic cell; Photopheresis; Transimmunization

Indexed keywords

CANCER VACCINE; CD4 ANTIGEN; INTERLEUKIN 10; METHOXSALEN; TRANSFORMING GROWTH FACTOR BETA; TUMOR ANTIGEN;

ADOPTIVE IMMUNOTHERAPY; ARTICLE; CANCER IMMUNOTHERAPY; CELL FUNCTION; CELL INTERACTION; CELL LINEAGE; CELL SURVIVAL; CLINICAL FEATURE; CLONAL ANERGY; CUTANEOUS T CELL LYMPHOMA; DENDRITIC CELL; DIAGNOSTIC VALUE; DISEASE COURSE; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOBIOLOGY; IMMUNOREGULATION; INFECTION RESISTANCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; TUMOR CELL;

CANCER VACCINES; DENDRITIC CELLS; HUMANS; IMMUNIZATION; IMMUNOTHERAPY; LYMPHOMA, T-CELL, CUTANEOUS; PROGNOSIS; SKIN NEOPLASMS; T-LYMPHOCYTES;

EID: 0141535444     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/1042819031000104033     Document Type: Article

References (40)

1. Jondal, M., Holm, G. and Wigzell, H. (1972) "Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells", Journal of Experimental Medicine 136, 207-215.
2. Broder, S., Edelson, R., Lutzner, M., Nelson, D.I., McDermott, R.P., Durn, M.E., Golmas, C.K., Meade, B.D. and Waldman, T.A. (1976) "The Sezary syndrome: a malignant proliferation of helper T cells", Journal of Clinical Investigation 58, 1297-1306.
3. Berger, C.L., Warburton, D., Raafat, J., LoGerfo, P. and Edelson, R.L. (1979) "Cutaneous T-cell lymphoma: neoplasm of T cells with helper activity", Blood 4, 642-651.
4. Kung, P.C., Berger, C.L., Goldstein, G., LoGerfo, P. and Edelson, R.L. (1981) "Cutaneous T-cell lymphoma: characterization by monoclonal antibodies", Blood 57, 261-266.
5. Lutzner, M.A., Edelson, R.L., Schein, P., Green, I., Kirkpatrick, C. and Aftab, A. (1975) "Cutaneous T-cell lymphomas: the Sézary syndrome, mycosis fungoides, and related disorders", Annals of Internal Medicine 83, 534-552.
6. Schuler, G. and Steinman, R.M. (1985) "Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro", Journal Experimental Medicine 161, 526-546.
7. Picker, L.J., Michie, S.A., Rott, L.S. and Butcher, E.C. (1990) "A unique phenotype of skin-associated lymphocytes in humans: preferential expression of the HECA-452 epitope by benign and malignant T cells at cutaneous sites", American Journal of Pathology 136, 1053-1068.
8. Fuhlbrigge, R., Kieffer, J.D., Armerding, D. and Kupper, T.S. (1997) "Cutaneous lymphocyte antigen (CLA) is a specialized form of PSGL-1 on skin homing T cells", Nature 389, 78-981.
9. Dummer, R., Heald, P.W., Nestle, F.O., Ludwig, E., Laine, E., Hemmi, S. and Burg, G. (1996) "Sezary syndrome T-cell clones display T-helper 2 cytokines and express the accessory factor-1 (interferon-gamma receptor beta-chain)", Blood 15, 1383-1389.
10. Ramsay, D.L., Meller, J.A. and Zackheim, H.S. (1995) "Topical treatment of early cutaneous T-cell lymphoma", Hematology, Oncology Clinics of North America 5, 1031-1056.
11. Quiros, P.A., Jones, G.W., Kacinski, B.M., Braverman, I., Heald, R.W., Edelson, R.L. and Wilson, L.D. (1997) "Total skin electron beam therapy followed by adjuvant psoralen/ulatraviolet - A light in the management of patients with T1 and T2 cutaneous T-cell lymphoma (mycosis fungoides)", International Journal of Radiation Oncology, Biology and Physics 38, 1027-1035.
12. Edelson, R.L., Berger, C.L., Gasparro, F.P., Jegasothy, B., Heald, P., Wintroub, B., Vonderheid, E., Knobler, R., Wolff, K., Plewig, G., McKiernan, G., Christiansen, I., Oster, M., Honigsmann, H., Wilford, H., Kokoschka, E., Rehle, T., Perez, M., Stingl, G. and Laroche, L. (1987) "Treatment of leukemic cutaneous T-cell lymphoma with extracorporeally-photoactivated 8-methoxy-psoralen", New England Journal of Medicine 316, 297-303.
13. Zic, J.A., Stricklin, G.P., Greer, J.P., Kinney, M.C., Shyr, Y., Wilson, D.C. and King, L.E. Jr (1996) "Long-term follow-up of patients with cutaneous T-cell lymphoma treated with extracorporeal photochemotherapy", Journal of the American Academy of Dermatology 35, 935-945.
14. Jiang, S.B., Dietz, S.B., Kim, M. and Lim, H.W. (1999) "Extracorporeal photochemotherapy for cutaneous T-cell lymphoma: a 9.7 year experience", Photodermatology, Photoimmunology and Photomedicine 15, 161-165.
15. Wollina, U., Liebold, K., Kaatz, M., Looks, A., Stuhlert, A. and Lange, D. (2000) "Survival of patients with cutaneous T-cell lymphoma after treatment with extracorporeal photochemotherapy", Oncology Reports 7, 1197-1201.
16. Crovetti, G., Carabelli, A., Berti, E., Guizzardi, M., Fossati, S., De Filippo, C. and Bertani, E. (2000) "Photopheresis in cutaneous T-cell lymphoma: five-year experience", International Journal of Artificial Organs 23, 55-62.
17. Berger, C.L., Longley, B.J., Imaeda, S., Christensen, I., Heald, P. and Edelson, R.L. (1998) "Tumor-specific peptides in cutaneous T-cell lymphoma: Association with class I major histocompatibility complex and possible derivation from the clonotypic T-cell receptor", International Journal of Cancer 76, 304-311.
18. Berger, C.L., Wang, N., Christensen, I., Longley, J., Heald, P. and Edelson, R.L. (1996) "The immune response to class I-associated tumor-specific cutaneous T-cell lymphoma antigens", Journal of Investigative Dermatology 107, 392-397.
19. Girardi, M., Schechner, J., Glusac, E., Berger, C. and Edelson, R. (2002) "Transimmunization and the evolution of extracorporeal photochemotherapy", Transfusion Apheresis Science 3, 181-190.
20. Berger, C.L., Xu, A.L., Hanlon, D., Lee, C., Schechner, J., Glusac, E., Christensen, I., Snyder, E., Holloway, V., Tigelaar, R. and Edelson, R.L. (2001) "Induction of human tumor-loaded dendritic cells", International Journal of Cancer 4, 438-447.
21. Berger, C.L., Hanlon, D., Kanada, D., Dhodapkar, M., Lombillo, V., Wang, N., Christensen, I., Howe, G., Crouch, J., El-Fishawy, P. and Edelson, R. (2002) "The growth of cutaneous T-cell lymphoma is stimulated by immature dendritic cells", Blood 99, 2929-2938.
22. Nickoloff, B.J. and Griffiths, C.E.M. (1990) "Intraepidermal but not dermal T lymphocytes are positive for a cell-cycle associated antigen (KI-67) in mycosis fungoides", American Journal of Pathology 136, 261-265.
23. Chu, A., Berger, C.L., Kung, P. and Edelson, R.L. (1982) "In situ identification of Langerhans cells in the dermal infiltrate of cutaneous T cell lymphoma", Journal of the American Academy of Dermatology 3, 350-354.
24. Banchereau, J. and Steinman, R.M. (1998) "Dendritic cells and the control of immunity", Nature 392, 245-252.
25. Inaba, K., Turley, S., Iyoda, T., Yamaide, F., Shimoyama, S., Reise, E., Sousa, C., Germain, R.N., Mellman, I. and Steinman, R.M. (2000) "The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli", Journal of Experimental Medicine 191, 927-936.
26. Feng, H., Zeng, Y., Graner, M.W., Likhacheva, A. and Katsanis, E. (2003) "Exogenous stress proteins enhance the immunogenicity of apoptotic tumor cells and stimulate antitumor immunity", Blood 101, 245-252.
27. + T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function", Journal of Experimental Medicine 193, 1295-1301.
28. + regulatory T cells prevent graft rejection: CTLA-4 and IL10-dependent immunoregulation of alloresponses", Journal of Immunology 168, 1080-1086.
29. + regulatory T cells is mediated by cell surface-bound transforming growth factor β, Journal of Experimental Medicine 194, 629-644.
30. + immunoregulatory T cells hinder tumor immunotherapy?", Journal of Immunotherapy 25, 202-206.
31. Steinman, R.M. and Pope, M. (2002) "Exploiting dendritic cells to improve vaccine efficacy", Journal of Clinical Investigation 109, 1519-1526.
32. + T cells with regulatory properties by repetitive stimulation with allogeneic immature dendritic cells", Journal of Experimental Medicine 192, 1213-1222.
33. 319 phosphorylation: a potential role for tyrosine phosphatases", Journal of Immunology 168, 4420-4429.
34. Berger, C.L., Cohen, J., Trinh, J., Hanlon, D. and Edelson, R.L. (2002) "The growth of cutaneous T Cell lymphoma is driven by auto-antigen and regulated by CTLA-4", Journal of Investigative Dermatology 119, 296a.
35. Rook, A.H., Wood, G.S., Yoo, E.K., Elenitsas, R., Kao, D.M.F., Sherman, M.L., Witmer, W.K., Rockwell, K.A., Shane, R.B., Lessin, S.R. and Vonderheid, E.C. (1999) "Interleukin-12 therapy of cutaneous T-cell lymphoma induces lesion regression and cytotoxic T cell responses", Blood 94, 902-908.
36. Prud'homme, G.J. and Piccirillo, C.A. (2000) "The inhibitory effects of transforming growth factor-beta-1 (TGF-β1) in autoimmune diseases", Journal of Autoimmunity 14, 23-42.
37. + progenitors", Journal of Leukocyte Biology 66, 781-791.
38. Guironnet, G., Dezuter-Dambuyant, C., Vincent, C., Bechetoille, N., Schmitt, D. and Péguet-Navarro, J. (2002) "Antagonistic effects of IL-4 and TGF-β1 on Langerhans cell-related antigen expression by human monocytes", Journal of Leukocyte Biology 71, 845-853.
39. Gilchrest, B.A., Parrish, J.A., Tanenbaum, L., Haynes, J.A. and Fitzpatrick, T.B. (1976) "Oral methoxsalen photochemotherapy of mycosis fungoides", Cancer 38, 683-689.
40. Chambers, C.A., Kuhns, M., Egen, J.G. and Allison, J.P. (2001) "CTLA-4-medited inhibition in regulation of T cell responses: Mechanisms and manipulation in tumor immunotherapy", Annual Reviews of Immunology 19, 565-594.